Answers are grounded in this paper and cite their sources.
Chronic active lesions are common, are associated with more aggressive disease, exert ongoing tissue damage, and occur even in individuals treated with effective disease-modifying therapies. These results prompt the planning of MRI-based clinical trials aimed at treating perilesional chronic inflammation in MS.
No takes yet. Share an insight, caveat, or question.
Absinta et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: